The COVID-19 Pandemic – News and Features

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Women have a higher proportion of key immune cells between puberty and menopause, which may be linked to the sex hormone estrogen and explain why they are less susceptible to certain infectious diseases than men.

People living with long COVID often feel dismissed, disbelieved and unsupported by their healthcare providers, according to a new study from the University of Surrey.

With advanced data analysis and machine learning, scientists have identified a set of COVID-19-derived molecular mimics that are most likely to be involved in triggering autoimmunity.

Researchers at the University of Cologne have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential future infections.

In a study of 130 volunteers conducted at the Federal University of São Carlos, a drastic decrease in heart rate variability, i.e. the heart’s ability to adapt to environmental and physiological demands, was observed up to six weeks after infection.

This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and reducing errors.

A breakthrough in safely delivering therapeutic DNA to cells using lipid nanoparticles could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

When consumed in chili during pregnancy, beans may help lower one’s risk for gestational diabetes, according to new research.

Early tests suggest that an antibody-based therapy is safe, with no harmful effects on healthy cells, suggesting that it could be a promising treatment to help fight mucormycosis in people with weakened immune systems.